Retatrutide

GLP-1 / GIP / Glucagon triple agonist

Investigational peptide

Overview

Retatrutide is an investigational peptide that a pharmaceutical company is studying in clinical trials. It acts on three hormone receptors (GLP-1, GIP and glucagon). It is not FDA-approved and is not available as an approved medicine.

Members only

Scanned your vial? Log in to see your full guide.

The full Retatrutide guide is free for members. Log in, or create a free account, and it opens right here on this same page.

Free account: guides for every vial. Compare membership tiers.

What members get on this page

The complete member guide for this exact vial
Interactive member reference tool
Research summary with confidence ratings (Certain / Likely / Guessing)
Free with a member account (sign-up required)
Optional paid coaching: nutrition, training, weekly check-ins

Want a coach in your corner?

SOTRH coaching covers nutrition, training and everyday habits, with weekly check-ins and personal support.

Start coaching Compare membership tiers

← All vial guides